Capital Research Global Investors
IART icon

Capital Research Global Investors’s Integra LifeSciences IART Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-825,742
Closed -$18.2M 448
2025
Q1
$18.2M Sell
825,742
-574,817
-41% -$12.6M ﹤0.01% 409
2024
Q4
$31.8M Buy
1,400,559
+95,944
+7% +$2.18M 0.01% 389
2024
Q3
$23.7M Sell
1,304,615
-1,123,994
-46% -$20.4M ﹤0.01% 379
2024
Q2
$70.8M Sell
2,428,609
-3,490,372
-59% -$102M 0.02% 309
2024
Q1
$210M Buy
5,918,981
+1,621,655
+38% +$57.5M 0.05% 222
2023
Q4
$187M Buy
4,297,326
+1,228,996
+40% +$53.5M 0.05% 236
2023
Q3
$117M Sell
3,068,330
-189,816
-6% -$7.25M 0.03% 260
2023
Q2
$134M Sell
3,258,146
-565,580
-15% -$23.3M 0.04% 262
2023
Q1
$220M Hold
3,823,726
0.06% 214
2022
Q4
$214M Buy
3,823,726
+702,779
+23% +$39.4M 0.06% 208
2022
Q3
$132M Sell
3,120,947
-748,823
-19% -$31.7M 0.04% 239
2022
Q2
$209M Sell
3,869,770
-2,948,154
-43% -$159M 0.07% 206
2022
Q1
$438M Sell
6,817,924
-1,401,209
-17% -$90M 0.11% 166
2021
Q4
$551M Sell
8,219,133
-31,319
-0.4% -$2.1M 0.12% 157
2021
Q3
$565M Sell
8,250,452
-1,977
-0% -$135K 0.13% 151
2021
Q2
$563M Buy
8,252,429
+22,198
+0.3% +$1.51M 0.13% 152
2021
Q1
$569M Sell
8,230,231
-7,050
-0.1% -$487K 0.14% 145
2020
Q4
$535M Sell
8,237,281
-722,295
-8% -$46.9M 0.14% 151
2020
Q3
$423M Sell
8,959,576
-370,870
-4% -$17.5M 0.13% 154
2020
Q2
$438M Buy
9,330,446
+176,447
+2% +$8.29M 0.14% 142
2020
Q1
$409M Buy
9,153,999
+33,046
+0.4% +$1.48M 0.16% 121
2019
Q4
$532M Buy
9,120,953
+65,402
+0.7% +$3.81M 0.16% 128
2019
Q3
$544M Buy
9,055,551
+385
+0% +$23.1K 0.18% 121
2019
Q2
$506M Buy
9,055,166
+68,131
+0.8% +$3.81M 0.16% 131
2019
Q1
$501M Sell
8,987,035
-653,508
-7% -$36.4M 0.16% 131
2018
Q4
$435M Sell
9,640,543
-545,675
-5% -$24.6M 0.15% 136
2018
Q3
$671M Buy
10,186,218
+423,324
+4% +$27.9M 0.2% 111
2018
Q2
$629M Buy
9,762,894
+149,488
+2% +$9.63M 0.17% 121
2018
Q1
$532M Buy
9,613,406
+280
+0% +$15.5K 0.15% 136
2017
Q4
$460M Buy
9,613,126
+3,556,194
+59% +$170M 0.14% 142
2017
Q3
$306M Buy
6,056,932
+2,159,644
+55% +$109M 0.09% 178
2017
Q2
$212M Buy
3,897,288
+2,705,488
+227% +$147M 0.07% 221
2017
Q1
$50.2M Buy
1,191,800
+260,400
+28% +$11M 0.02% 340
2016
Q4
$79.9M Buy
931,400
+17,400
+2% +$1.49M 0.03% 300
2016
Q3
$75.5M Buy
914,000
+403,113
+79% +$33.3M 0.02% 293
2016
Q2
$40.8M Buy
+510,887
New +$40.8M 0.01% 341